Fate Therapeutics
- Biological Products, Except Diagnostic Substances
- San Diego, California
Compensation history
Top executives at Fate Therapeutics received an average of $2M per person in annual compensation from 2012 to 2021.
Average pay of disclosed executives at Fate Therapeutics
By year
- 2021
JW$12MJ. Scott WolchkoPresident, Chief Executive Officer and DirectorMP$8MMark PlavsicChief Technology OfficerBV$6MBahram ValamehrChief Research and Development OfficerCT$6MCindy R. TahlGeneral Counsel and Corporate SecretaryYC$6MYu-Waye ChuChief Medical OfficerED$6MEdward J. Dulac IIIChief Financial Officer
Executives
We found 11 executives who work or worked at Fate Therapeutics.
J Wolchko
Fate Therapeutics
Chief Executive Officer
Edward Dulac
Fate Therapeutics
Chief Financial Officer
Bahram Valamehr
Fate Therapeutics
Chief Research and Development Officer
Cindy Tahl
Fate Therapeutics
General Counsel
Yu-Waye Chu
Fate Therapeutics
Chief Medical Officer
Mark Plavsic
Fate Therapeutics
Chief Technology Officer
Daniel Shoemaker
Fate Therapeutics
Chief Scientific Officer
Christopher Storgard
Fate Therapeutics
Chief Medical Officer
News
About Fate Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryBiological Products, Except Diagnostic Substances
- Address12278 Scripps Summit Drive, San Diego, California 92131
- Phone858.875.1803
- Fiscal year endDecember 31
Source: SEC filings on April 25, 2022, April 21, 2021, March 22, 2019, March 16, 2018, March 22, 2017, March 30, 2016, April 2, 2015, and April 25, 2014.